全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Sclerotherapy with Leuprolide and Cefoperazone Sulbactam in the Management of Ovarian Endometriomas under Ultrasound Guidance: A Novel Approach

DOI: 10.4236/asm.2022.121004, PP. 34-46

Keywords: Ovarian Endometriomas (OE), Infertility (IF), Sclerosing Agent (SA), Leuprolide with Cefoperazone Sulbactam (LCS), In Vitro Fertilization (IVF)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Endometriosis is an estrogen dependent gynecological disorder, which can occur throughout the reproductive age of women, causing chronic pelvic pain, substantial morbidity, and impaired fertility. It is clinically defined as the presence of ectopic endometrium resulting in sustained inflammatory reaction. In India, about 29,000,000 women suffer from endometriosis. Severe pelvic pain and recurrent endometriomas were observed even after surgery. We have conducted aspirations totally in 110 patients in which most of the patients were suffering from Stage III & Stage IV of endometriosis except for 7 patients for whom we have done as primary therapy for endometriomas. Among 110 patients, 4 patients didn’t turn up for follow up after first aspiration. This pilot study conducted with 110 patients in Ponni Hospital and Fertility Research Centre, Madurai aimed to evaluate pregnancy outcome in 51 infertile patients, and to alleviate pelvic pain, to restore a healthy sexual life and to reduce the recurrence rate of Ovarian Endometriomas (OE) in 59 patients, who did not seek fertility, After using the newer sclerosing agent Leuprolide with Cefoperazone Sulbactam (LCS) under ultrasound guidance. This prospective pilot study resulted in a highly significant achievement in pregnancy where 41 patients conceived out of 51 patients (80.39%) only 6 are in ongoing treatment. Those who didn’t seek fertility were 59 of which 43 have completed family 13 have one child and 3 unmarried girls. 96.61% were relieved of pain and recurrence and restored healthy sexual life, 2 are in ongoing treatment. We have not encountered any adverse effects during this treatment.

References

[1]  Sindan, N., Bhandari, A., Sindan, N., Kc, R., Xia, E. and Lin, Y. (2021) Clinical Factors Influencing the Pregnancy Outcome after Laparoscopic Treatment in Endometriosis-Associated Infertility Patients: A Retrospective Study. American Journal of Translational Research, 13, 2399-2409.
[2]  Alborzi, S., Askary, E., Keramati, P., Moradi Alamdarloo, S., Poordast, T., Ashraf, M.A., et al. (2021) Assisted Reproductive Technique Outcomes in Patients with Endometrioma Undergoing Scelerotheraphy vs Laparoscopic Cystectomy: Prospective Cross-Sectional Study. Reproductive Medicine and Biology, 20, 313-320.
https://doi.org/10.1002/rmb2.12386
[3]  Burney, R.O. and Giudice, L.C. (2012) Pathogenesis and Pathophysiology of Endometriosis. Fertility and Sterility, 98, 511-519.
https://doi.org/10.1016/j.fertnstert.2012.06.029
[4]  Hoyle, A.T. and Puckett, Y. (2021) Endometrioma. StatPearls.
[5]  Visconti, F. and Di Carlo, C. (2021) The Etonogestrel Contraceptive Implant as a Therapy for Endometriosis. In: Genazzani, A.R., Nisolle, M., Petraglia, F. and Taylor R.N., Eds., Endometriosis Pathogenesis, Clinical Impact and Management, Springer, Cham, 65-71.
https://doi.org/10.1007/978-3-030-57866-4_7
[6]  Birbarah, C., Tebache, L., Brichant, G. and Nisolle, M. (2021) What Is the Place of Surgery of Deep Endometriosis in Infertile and Pelvic Pain Patients? In: Genazzani, A.R., Nisolle, M., Petraglia, F. and Taylor, R.N., Eds., Endometriosis Pathogenesis, Clinical Impact and Management, Springer, Cham, 83-95.
https://doi.org/10.1007/978-3-030-57866-4_9
[7]  Kolanska, K., Alijotas-Reig, J., Cohen, J., Cheloufi, M., Selleret, L., d’Argent, E., et al. (2021) Endometriosis with Infertility: A Comprehensive Review on the Role of Immune Deregulation and Immunomodulation Therapy. American Journal of Reproductive Immunology, 85, Article ID: e13384.
https://doi.org/10.1111/aji.13384
[8]  Bloski, T. and Pierson, R. (2008) Endometriosis and Chronic Pelvic Pain: Unraveling the Mystery Behind This Complex Condition. Nursing for Women’s Health, 12, 382-395.
https://doi.org/10.1111/j.1751-486X.2008.00362.x
[9]  Kuznetsov, L., Dworzynski, K., Davies, M. and Overton, C (2017) Diagnosis and Management of endometriosis: Summary of NICE Guidance. BMJ, 358, Article No. j3935.
https://doi.org/10.1136/bmj.j3935
[10]  Cohen, A., Almog, B. and Tulandi, T. (2017) Scelerotheraphy in the Management of Ovarian Endometrioma: Systematic Review and Meta-Analysis. Fertility and Sterility, 108, 117-124.e5.
https://doi.org/10.1016/j.fertnstert.2017.05.015
[11]  Worthington-Kirsch, R.L. (2005) Injection Scelerotheraphy. Seminars in Interventional Radiology, 22, 209-217.
https://doi.org/10.1055/s-2005-921954
[12]  Patz Jr., E.F., McAdams, H.P., Erasmus, J.J., Goodman, P.C., Culhane, D.K., Gilkeson, R.C. and Herndon, J. (1998) Scelerotheraphy for Malignant Pleural Effusions: A Prospective Randomized Trial of Bleomycin vs Doxycycline with Small-Bore Catheter Drainage. Chest, 113, 1305-11.
https://doi.org/10.1378/chest.113.5.1305
[13]  Barnacle, A.M., Theodorou, M., Maling, S.J. and Abou-Rayyah, Y. (2016) Sclerotherapy Treatment of Orbital Lymphatic Malformations: A Large Single-Centre Experience. British Journal of Ophthalmology, 100, 204-208.
https://doi.org/10.1136/bjophthalmol-2015-306657
[14]  Rafique, S. and Decherney, A.H. (2017) Medical Management of Endometriosis. Clinical Obstetrics and Gynecology, 60, 485-496.
https://doi.org/10.1097/GRF.0000000000000292
[15]  Schindler, A.E. (2011) Dienogest in Long-Term Treatment of Endometriosis. International Journal of Women’s Health, 3, 175-184.
https://doi.org/10.2147/IJWH.S5633
[16]  Wacharachawana, S., Phaliwong, P., Prommas, S., Smanchat, B., Bhamarapravatana, K. and Suwannarurk, K. (2021) Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy. BioMed Research International, 2021, Article ID: 6679641.
https://doi.org/10.1155/2021/6679641
[17]  Parazzini, F., Bertulessi, C., Pasini, A., Rosati, M., Di Stefano, F., Shonauer, S., et al. (2005) Determinants of Short Term Recurrence Rate of Endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 121, 216-219.
https://doi.org/10.1016/j.ejogrb.2004.11.033
[18]  Vignali, M., Bianchi, S., Candiani, M., Spadaccini, G., Oggioni, G. and Busacca, M. (2005) Surgical Treatment of Deep Endometriosis and Risk of Recurrence. Journal of Minimally Invasive Gynecology, 12, 508-513.
https://doi.org/10.1016/j.jmig.2005.06.016
[19]  Exacoustos, C., Zupi, E., Amadio, A., Amoroso, C., Szabolcs, B., Romanini, M.E., et al. (2006) Recurrence of Endometriomas after Laparoscopic Removal: Sonographic and Clinical Follow-up and Indication for Second Surgery. Journal of Minimally Invasive Gynecology, 13, 281-288.
https://doi.org/10.1016/j.jmig.2006.03.002
[20]  Miquel, L., Preaubert, L., Gnisci, A., Resseguier, N., Pivano, A., Perrin, J., et al. (2020) Endometrioma Ethanol Scelerotheraphy Could Increase IVF Live Birth Rate in Women with Moderate-Severe Endometriosis. PLoS ONE, 15, e0239846.
https://doi.org/10.1371/journal.pone.0239846
[21]  García-Tejedor, A., Castellarnau, M., Ponce, J., Fernández, M.E. and Burdio, F. (2015) Ethanol Scelerotheraphy of Ovarian Endometrioma: A Safe and Effective Minimal Invasive Procedure. Preliminary Results. European Journal of Obstetrics & Gynecology and Reproductive Biology, 187, 25-29.
https://doi.org/10.1016/j.ejogrb.2015.02.004
[22]  Gatta, G., Parlato, V., Di Grezia, G., Porto, A., Cappabianca, S., Grassi, R. and Rotondo, A. (2010) Ultrasound-Guided Aspiration and Ethanol Sclerotherapy for Treating Endometrial Cysts. La radiologia medica, 115, 1330-1339.
https://doi.org/10.1007/s11547-010-0586-0
[23]  Wang, S.M., Cai, H.Q., Dong, X.Q., Fan, Q.L., Wang, L.L., Shao, X.H. and Zhang, L. W. (2015) Correlation between Ovarian Chocolate Cyst and Serum Carbohydrate Antigen 125 Level and the Effect of Ultrasound-Guided Interventional Sclerotherapy on Serum Carbohydrate Antigen 125 Level. Journal of Obstetrics and Gynaecology Research, 41, 92-98.
https://doi.org/10.1111/jog.12491
[24]  Yazbeck, C., Madelenat, P., Ayel, J.P., Jacquesson, L., Bontoux, L.M., Solal, P. and Hazout, A. (2009) Ethanol Sclerotherapy: A Treatment Option for Ovarian Endometriomas before Ovarian Stimulation. Reproductive Biomedicine Online, 19, 121-125.
https://doi.org/10.1016/S1472-6483(10)60055-7
[25]  Agostini, A., De Lapparent, T., Collette, E., Capelle, M., Cravello, L. and Blanc, B. (2007) In Situ Methotrexate Injection for Treatment of Recurrent Endometriotic Cysts. European Journal of Obstetrics & Gynecology and Reproductive Biology, 130, 129-131.
https://doi.org/10.1016/j.ejogrb.2006.01.015

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133